Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients

PURPOSE: The German guideline for breast cancer recommends using chemotherapy (CHT) in patients with hormone receptor-positive and node-positive, invasive breast cancer. The aim of this study was to analyse the effects of CHT in this patient group on overall survival (OS) and distant metastases-free...

Descripción completa

Detalles Bibliográficos
Autores principales: Taubenhansl, Clara, Ortmann, Olaf, Gerken, Michael, Inwald, Elisabeth C., Klinkhammer-Schalke, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033056/
https://www.ncbi.nlm.nih.gov/pubmed/31749031
http://dx.doi.org/10.1007/s00404-019-05387-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033056/
https://www.ncbi.nlm.nih.gov/pubmed/31749031
http://dx.doi.org/10.1007/s00404-019-05387-3

Ejemplares similares